HuagongsheHuagongshe Chemistry Print Report · For research reference only
1-(Piperidin-4-yl)-3-propyl-1,3-dihydro-2H-benzimidazol-2-one → 1,1-Dioxido-2-(4-(4-(3-n-propyl-2-oxo-1-benzimidazolinyl)piperidin-1-yl)pentyl)-5-chloro-1,2-benzisothiazol-3(2H)-one
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | 1-(Piperidin-4-yl)-3-propyl-1,3-dihydro-2H-benzimidazol-2-one | HCID 15895135 | — |
| Reactant | 1,1-dioxido-2-(4-oxo-pentyl)-5-chloro-1,2-benzisothiazol-3(2H)-one | HCID 18695979 | — |
| Product | 1,1-Dioxido-2-(4-(4-(3-n-propyl-2-oxo-1-benzimidazolinyl)piperidin-1-yl)pentyl)-5-chloro-1,2-benzisothiazol-3(2H)-one | HCID 18695967 | — |
Reaction Steps
Starting with 4-(3-n-propyl-2-oxo-1-benzimidazolinyl)piperidine and 1,1-dioxido-2-(4-oxo-pentyl)-5-chloro-1,2-benzisothiazol-3(2H)-one and following the procedure of Example 13, the title compound is obtained.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US05952351 |
| Source dataset | uspto-grants-1999_09 |
| ORD ID | ord-14472566878a49b38528865ec60c8a7c |
| Source note | uspto-grants-1999_09 |